All Stories

Roche looks to expand and upgrade US research centers as part of $50B investment strategy in the country

Roche has pledged to upgrade three R&D sites and pointed to the recent announcement of a new home for its cardiovascular, renal and metabolism R&D work as proof the Swiss pharma is investing serious money in the U.S.

Apr 22, 2025 - 12:46
 0
Roche looks to expand and upgrade US research centers as part of $50B investment strategy in the country
Roche has pledged to upgrade three R&D sites and pointed to the recent announcement of a new home for its cardiovascular, renal and metabolism R&D work as proof the Swiss pharma is investing serious money in the U.S.
Read More

Tags:

Previous Article

Author Correction: Structure of the human dopamine transporter in complex with c...

Next Article

STAT+: FDA Commissioner Marty Makary announces three new hires in leadership team

Related Posts

J&J opts out of licensing Genmab's Darzalex challenger after look at phase 1/2 data

J&J opts out of licensing Genmab's Darzalex challenger ...

Mar 10, 2025  0

Monte Rosa's broad molecular glue degrader plan comes unstuck, but prostate cancer work continues

Monte Rosa's broad molecular glue degrader plan comes u...

Mar 20, 2025  0

J&J, Protagonist's oral psoriasis prospect bests BMS' Sotyktu in pair of phase 3 trials

J&J, Protagonist's oral psoriasis prospect bests BMS' S...

Mar 10, 2025  0